From the publishers of JADPRO

MPN Resource Center

Advertisement

Last Updated: Friday, March 12, 2021

In a retrospective study of 300 Caucasian and non-Caucasian patients with MPNs, researchers did not find a significant difference in the rate of thrombotic or hemorrhagic events between the two arms. However, there was a statistically significant difference in median survival: 29 years (95% CI: 21.8–not reached) in the Caucasian arm versus 13 years (95% CI: 5.7–22.7) in the non-Caucasian arm (p = .016).

Hematology/Oncology and Stem Cell Therapy
Advertisement
News & Literature Highlights
Advertisement
Advertisement